Hernández-Hernández Rafael, Octavio-Seijas José Andrés, Morr Igor, López-Rivera Jesús, Gúzman-Franolic Mónica L, Costantini-Olmos Antonieta P, Silva Egle, Méndez-Amaya Nedina Coromoto, Duín Amanda, Vásquez Dámaso, Ruíz-Lugo José Félix, Marval José, Duín Juan Carlos Camacho, Ponte-Negretti Carlos Ignacio, Beaney Thomas, Kobeissi Elsa, Poulter Neil R
Hypertension and Cardiovascular Risk Factors Clinic, Clinical Pharmacology Unit, Dean of Health Sciences, Universidad Centroccidental Lisandro Alvarado, Barquisimeto, Venezuela.
Department of Experimental Cardiology, Tropical Medicine Institute, Universidad Central de Venezuela, Caracas, Venezuela.
Eur Heart J Suppl. 2019 Apr;21(Suppl D):D124-D126. doi: 10.1093/eurheartj/suz075. Epub 2019 Apr 24.
Cardiovascular diseases, mainly coronary heart disease and stroke, are the first cause of death in Venezuela; and hypertension is the main risk factor. May Measurement Month (MMM) is a global initiative aimed at raising awareness of elevated blood pressure (BP) and to act as a temporary solution to the lack of regular screening programmes. Some representative studies indicate prevalence of hypertension in Venezuela between 24 and 39%, and control rate around 20%. Sixty-four sites were included to participate in MMM, mainly in pharmacies. Physical measurements included height, weight, and abdominal circumference. Blood pressure was measured in the sitting position three times after resting for 5 min, 1 min apart, using validated oscillometric devices. 21 644 individuals were screened. After multiple imputation, 10 584 individuals [48.9% (50.7% male; 47.7% female)] had hypertension. Of individuals not receiving antihypertensive medication, 1538 (12.2%) were hypertensive. Of individuals receiving antihypertensive medication, 2974 (32.9%) had uncontrolled BP. About 16% had obesity calculated by body mass index; 43.8% of women and 20.7% of men had abdominal obesity. This was the largest BP screening carried out in Venezuela, in which 48.9% of the individuals had elevated BP, untreated hypertension was 12.2%, and one-third of subjects taking treatment were not controlled. About 16% had obesity by body mass index, and abdominal obesity is more common in women. These results suggest that repeated screening like MMM17 can identify hypertension in important numbers and can also evaluate programmes of hypertension treatment and control in Venezuela.
心血管疾病,主要是冠心病和中风,是委内瑞拉的首要死因;高血压是主要危险因素。五月测量月(MMM)是一项全球倡议,旨在提高对血压升高的认识,并作为缺乏常规筛查项目的临时解决方案。一些代表性研究表明,委内瑞拉高血压患病率在24%至39%之间,控制率约为20%。64个地点参与了五月测量月活动,主要是在药店。身体测量包括身高、体重和腹围。使用经过验证的示波装置,在休息5分钟后,以坐姿测量血压3次,每次间隔1分钟。对21644人进行了筛查。经过多重插补,10584人(48.9%,男性占50.7%,女性占47.7%)患有高血压。在未接受抗高血压药物治疗的个体中,1538人(12.2%)患有高血压。在接受抗高血压药物治疗的个体中,2974人(32.9%)血压未得到控制。约16%的人通过体重指数计算患有肥胖症;43.8%的女性和20.7%的男性患有腹型肥胖。这是在委内瑞拉开展的最大规模的血压筛查,其中48.9%的个体血压升高,未治疗的高血压为12.2%,三分之一接受治疗的受试者血压未得到控制。约16%的人通过体重指数患有肥胖症,腹型肥胖在女性中更为常见。这些结果表明,像五月测量月这样的重复筛查可以识别出大量高血压患者,还可以评估委内瑞拉的高血压治疗和控制项目。